In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Patients in the DUPIXENT groups saw improved lung function in as little as 2 weeks.

Learn how DUPIXENT helped treat patients 12+ years old with their moderate-to-severe asthma.

RESULTS IN PATIENTS
AGES 12+ YEARS